Collaborations & Alliances

Gilead, WuXi PharmaTech in Analytical Testing Alliance

Will operate a dedicated, cGMP analytical testing facility in Shanghai

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Gilead Sciences and WuXi PharmaTech (Cayman) Inc. have entered into a strategic partnership to conduct analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products. WuXi will equip and operate a dedicated, fully cGMP-compliant 12,500-sq.-ft. analytical testing facility in Shanghai that will provide analytical and stability services, including analytical method development, transfer and validation for IND/NDA submissi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters